Europe’s largest biotechnology congress, bridging the gap between pharma, academia and clinicians to foster meaningful collaborations.

The 3-day event will take place in 2025 in Basel, a thriving hub of innovation. They are aiming to bring 3500 global executives, 400 speakers and 50 start-ups.

The agenda covers everything from the use and management of multiomic data to the development of personalised therapies as well as covering the actual generation of the data.

See the event details here.